EAVE II logo


(*Completed) The impact of COVID-19 vaccines in pregnancy, children and young people, and vulnerable groups (DaC-VaP-2) study.

The DaC-VaP-2 project works to use UK-wide data to study the uptake, safety and effectiveness of COVID-19 vaccines. It is an ongoing, EAVE II associated project.

Find out more at: 'What are connected projects?'

About DaC-VaP-2

Find out more about our research: what we are doing, who we are working with and why it is important.

Meet our team

Hear more about the DaC-VaP-2 team, from our researchers and analysts, to our operations and PPIE personnel.

Funders and Partners

A summary of our funders, partners and other contributing organisations.

Our Publications

A summary of the publications members of the DaC-VaP-2 team have written or significantly contributed to. Our research is still ongoing, and expect more articles to be published soon.

Watch our webinar

On 22 September 2022, members of the DaC-VaP-2 team came together to deliver a webinar discussing the project's commitment to PPI, the national data assets involved and how they can be accessed, how the team developed their UK-wide analyses as well as international partnerships.

Related projects

Visit the DaC-VaP research site

Visit the Vaccine Breakthroughs Project research site

Visit the Vaccine Booster Breakthroughs research site

Visit the COALESCE research site